Read the latest blogs from across our work within the secondary breast cancer community. From blogs on fundraising, research findings, information sharing, corporate achievements, community support and stories, celebrate with us as we work together to Make 2nds Count.

IMG 3680
16th May 2023

Taking On The Make 2nds Count Skydive: Evan's Story

We are sharing a very special blog today from one of our amazing fundraisers - Evan Moffitt, son of one of our Trustees, Heather.

He has chosen to share his personal story with us, and we are so proud and grateful to him for the opportunity to hear from him directly.

Read more  Fundraising
Claire Goodwin
14th May 2023

SBC & Me

SBC & Me Date of Diagnosis 13/01/2023 Current Treatment Line I am just about to start a chemo drug called Abraxane and immunotherapy. I'll go in for treatments on a four week cycle, with three on and one off.

Read more  SBC & Me Education
HER2 CNS Survey
9th May 2023

HER2-CNS SURVEILLANCE study awarded funding by Make 2nds Count

Make 2nds Count is proud to announce that £219,560 in research funding, across 3 years, has been awarded to a new study taking place across the UK & Ireland investigating screening secondary breast cancer patients for brain metastases before they become symptomatic. Recruitment of patients will start in 2024.

Read more  Research News
Karen Watson
7th May 2023

SBC & Me

SBC & Me Date of Diagnosis 08/04/2022 Current Treatment Line I am on my first line of treatment taking Letrozole and Palbociclib and about to start cycle 10. How does SBC effect your life?

Read more  SBC & Me Education
Di Rohan
30th April 2023

SBC & Me

SBC & Me Date of Diagnosis 26/05/2022 Current Treatment Line Abemaciclib 150mg twice a day Denosumab injections monthly Fulvestrant injections monthly oxycodone for pain relief How does SBC effect your life? I am a very strong & positive person & i try very hard to do as much as i did before diagnosis, The fatigue gets to me more than anything & some days i can sleep for 14 hours & others i don’t even have a nap.

Read more 
Susan Woods 1920 1080 px v2
26th April 2023

New Clinical Trial Results on Temozolomide & Brain Metastases

Breast cancer spreading to the brain (brain metastases, or brain mets) can occur in up to 25-55% of HER2-positive secondary breast cancer patients. Brain metastases in secondary breast cancer patients is treated with radiotherapy and/or surgery.

Read more 
Stef Allan Evie
25th April 2023

Great North Run 2023: Kirsten's Story

Kirsten is taking part in the Great North Run in September 2023, her story is below: Can you tell me a little about yourself? My name is Kirsten, I am 38 years old and work as the Head of Finance for a Housing Association based in Midlothian.

Read more 
Rebecca Moses
23rd April 2023

SBC & Me

SBC & Me Date of Diagnosis 01/06/2022 Current Treatment Line Ribociclib + Letrozole + Zoladex + Denosumab How does SBC effect your life? Where do you begin with this?

Read more  SBC & Me Education
Katie Bratley
16th April 2023

SBC & Me

SBC & Me Date of Diagnosis 14/09/2022 Current Treatment Line Paclitaxel and Phesgo How does SBC effect your life? I am still very early on so I’m still getting use to it all.

Read more  SBC & Me Education
SMC Approval
12th April 2023

SMC Approval for trastuzumab deruxtecan (Enhertu®)

The Scottish Medicines Consortium (SMC) has announced that trastuzumab deruxtecan (Enhertu®) has been approved for usage within NHSScotland for metastatic HER2-positive breast cancer patients who have received one or more prior anti-HER2-based regimens. The National Institute for Health and Care Excellence (NICE) approved trastuzumab deruxtecan for this same patient cohort in NHS England & Wales in December 2022.

Read more 
image0 v2
29th March 2023

Walking for a Cause: Hannah's Story

Can you tell me more about why you chose to fundraise for us? I am a big believer that sometimes the smaller charities often get overlooked and therefore do not get the same funding as some of the larger charities.

Read more 
337029459 710791127447940 7975470810137914360 n
22nd March 2023

ASCENT-03: A New UK Clinical Trial for TRODELVY® & Metastatic Triple Negative Breast Cancer

Sacituzumab govitecan-hziy (known by the trade name TRODELVY®) was approved for NHS usage in 2022 for secondary TNBC patients, who have had two or more systemic therapies (such as chemotherapies), with at least one of these being for advanced disease. TRODELVY® was approved for this demographic of secondary TNBC patients because a phase 3 clinical trial (known as the ASCENT trial) showed positive patient outcomes.

Read more 
FINAL WoutStrapline 5
20th March 2023

Make 2nds Count statement

Make 2nds Count is aware that founder Lisa Fleming has spoken on social media about legal action she has brought against the charity. The charity will not comment about the active tribunal other than to confirm that we refute all aspects of the claim.

Read more 
Katherine Tremain
19th March 2023

SBC & My Treatment

SBC & Me How does secondary breast cancer affect your life? I do get exhausted, the tiredness suddenly hits me.

Read more  SBC & Me Education
Blog header
7th March 2023

The UK might reciprocate American FDA drug approval

The Food and Drug Administration (FDA) is responsible for approving drugs for disease treatment in America. Typically, before a new cancer drug is approved for usage in the UK by the Medicines and Healthcare products Regulatory Agency (MHRA), which has a separate approval process, the drug will initially get approved for usage in America by the FDA first.

Read more 

older articles newer articles